Brainstorm Cell Therapeutics’s (BCLI) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Brainstorm Cell Therapeutics is a Buy.

Brainstorm Cell Therapeutics’s (BCLI) 20-Day exponential moving average is 0.59, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.

Brainstorm Cell Therapeutics’s (BCLI) 50-Day exponential moving average is 0.60, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.

Advanced Chart >

Brainstorm Cell Therapeutics (BCLI) Pivot Points

Feb 07, 2026, 05:20 AM

Classic

0.50

0.54

0.55

0.59

0.60

0.64

0.66

Fibonacci

0.54

0.56

0.57

0.59

0.61

0.62

0.64

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Brainstorm Cell Therapeutics (BCLI) Moving Averages

Feb 07, 2026, 05:20 AM

MA5

0.59Sell

MA10

0.60Sell

0.59Sell

MA20

0.59Sell

MA50

0.59Sell

0.60Sell

MA100

0.64Sell

0.66Sell

MA200

0.80Sell

0.84Sell

Brainstorm Cell Therapeutics’s (BCLI) 10-Day exponential moving average is 0.59, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.

Brainstorm Cell Therapeutics’s (BCLI) 100-Day exponential moving average is 0.66, while Brainstorm Cell Therapeutics’s (BCLI) share price is $0.57, making it a Sell.

Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 50-day simple moving average is 0.59, creating a Sell signal.

Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 100-day simple moving average is 0.64, creating a Sell signal.

Brainstorm Cell Therapeutics’s (BCLI) stock price is $0.57 and Brainstorm Cell Therapeutics’s (BCLI) 200-day simple moving average is 0.80, creating a Sell signal.

Brainstorm Cell Therapeutics (BCLI) Technical Indicators

Feb 07, 2026, 05:20 AM

RSI (14)

47.58

Neutral

STOCH (9,6)

23.57

Neutral

STOCHRSI (14)

36.41

Neutral

MACD (12,26)

<0.01

Buy

ADX (14)

27.06

Neutral

Williams %R

-66.39

Buy

CCI (14)

-16.41

Neutral

ATR (14)

0.05

Ultimate Oscillator

49.20

Neutral

ROC

-1.69

Sell

Brainstorm Cell Therapeutics’s (BCLI) Relative Strength Index (RSI) is 47.58, creating a Neutral signal.

Brainstorm Cell Therapeutics’s (BCLI) Trend Strength Indicator (ADX) is 27.06, creating a Neutral signal.

Brainstorm Cell Therapeutics’s (BCLI) Commodity Channel Index (CCI) is -16.41, creating a Neutral signal.

Brainstorm Cell Therapeutics’s (BCLI) Price Rate of Change (ROC) is -1.69, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is BCLI a Buy, Hold, or Sell?

Based on BCLI’s technical indicators, BCLI is a Sell.

What is BCLI’s RSI (14)?

BCLI’s RSI (14) is 47.58, which suggests BCLI is a Neutral.

What is BCLI’s MACD?

BCLI’s MACD is <0.01, which suggests BCLI is a Buy.

What is BCLI’s 5-day moving average?

BCLI’s 5-day moving average is 0.59, which suggests BCLI is a Sell.

What is BCLI’s 20-day moving average?

BCLI 20-day moving average is 0.59, which suggests BCLI is a Sell.

What is BCLI’s 50-day moving average?

BCLI’s 50-day moving average is 0.59, which suggests BCLI is a Sell.

What is BCLI’s 200-day moving average?

BCLI’s 200-day moving average is 0.80, which suggests BCLI is a Sell.

What is BCLI’s Williams % R (14)?

BCLI’s Williams % R (14) is -66.39, which suggests BCLI is a Buy.

What is BCLI’s CCI (14)?

BCLI’s CCI (14) is -16.41, which suggests BCLI is a Neutral.